[ As at 25 March 2013 ]

 

Contents of circular in relation to a proposed subdivision of shares
(paragraph 13.11(1))

(1)A heading drawing attention to the importance of the circular and advising holders of shares who are in any doubt as to what action to take to consult appropriate independent professional advisers.
(2)A statement that Bursa Malaysia Securities Berhad takes no responsibility for the contents of the circular, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of the circular.
(3)The purpose of the circular.
(4)The reasons for and purposes of the proposed subdivision of shares.
(5)The details of the proposed subdivision and date on which the proposed subdivision of shares was announced.
(6)​The number, type and par value of the existing and proposed subdivided shares.
(7)The listed issuer's share price adjusted for the subdivision and the basis of determining the price.
(8)​The ranking of the proposed subdivided shares and treatment of any fractions.
(9)The details of any other intended corporate exercise/scheme which have been announced but not yet completed before the printing of the circular.
(10) The effects of the proposed subdivision on -
(a)the issued and paid-up capital and shares to be issued pursuant to existing share option schemes or shares to be issued pursuant to the exercise and/or conversion of existing convertible securities;
(b)​the net assets per share based on the latest audited consolidated financial statements; and
(c)​the earnings per share of the group.
(11)The expected timeframe for completion of the proposed subdivision.
(12)The monthly highest and lowest market prices of the listed shares transacted for the 12 months preceding the date of the circular and the last transacted price immediately before the announcement of the subdivision of shares and as at the latest practicable date before the printing of the circular.
(13)The approvals required for the proposed subdivision of shares and dates on which such approvals were obtained and conditions of the approvals.
(14)​A statement by the board of directors stating whether the exercise is in the best interest of the listed issuer.
(15) A recommendation from the board of directors as to the voting action that shareholders should take.
(16) An appendix containing the following information:
​​(a)a responsibility statement by the directors that the circular has been seen and approved by the directors of the listed issuer and that they collectively and individually accept full responsibility for the accuracy of the information given and confirm that after making all reasonable enquiries to the best of their knowledge and belief there are no other facts the omission of which would make any statement in the circular misleading;
​​(b)where a person is named in the circular as having advised the listed issuer or its directors, a statement that such adviser or expert has given and has not withdrawn its written consent to the inclusion of the adviser's or expert's name and/or letter (if applicable) in the form and context in which it is included; and
​​(c)a statement that from the date of the circular until the date of the general meeting the following documents (or copies of the documents) may be inspected at the registered office of the listed issuer:
​(i)the memorandum and articles of association;
​(ii) the audited financial statements of the listed issuer and/or group for the past 2 financial years and the latest unaudited results since the last audited  financial statements;
​(iii) all reports, letters or other documents, statement of financial position, valuations and statements by any expert, any part of which is extracted or referred to in the circular; and
​(iv)the letters of consent referred to in subparagraph (b) above.
(17) ​Any other information which the shareholders and their advisers would reasonably expect to find in a circular of that nature for the purpose of making an informed decision.

[ End of Appendix ]

Back to Top